Machine signal
Active cluster sell — 4 distinct insiders, $62.6M, window ends Oct 15, 2026.
Figures computed from official regulatory filings — .
Analysttarget 123.61 USD (-49%) · consensus 3.13/5 · 5 buy · 14 hold · 4 sell
Ownershipinsiders 7.34% · institutions 80.56% · short 9.4% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Moderna, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
4 buys2,770 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Hoge Stephen | Sell | $96.4K | SEC | ||
| Hoge Stephen |
| Exercise |
| $933.5K |
| Unusual size |
| SEC |
| Hoge Stephen | Sell | $8.6M | Unusual size | SEC |
| Hoge Stephen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hoge Stephen | Sell | $8.3M | Unusual size | SEC |
| Hoge Stephen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hoge Stephen | Exercise | $933.5K | SEC |
| Mock James M | Other | $133.8K | SEC |
| Mock James M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mock James M | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Hoge Stephen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hoge Stephen | Sell | $5.9M | SEC |
| Hoge Stephen | Exercise | $933.5K | Unusual size | SEC |
| Hoge Stephen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hoge Stephen | Exercise | $933.5K | Unusual size | SEC |
| Hoge Stephen | Sell | $5.8M | Unusual size | SEC |
| Mock James M | Sell | $2.7M | Unusual size | SEC |
| Mock James M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mock James M | Exercise | $614.1K | SEC |
| Mock James M | Sell | $2M | Unusual size | SEC |
| Mock James M | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Klinger Shannon Thyme | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Klinger Shannon Thyme | Other | $849.2K | Unusual size | SEC |
| Mock James M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Klinger Shannon Thyme | Exercise | n/a (No price was disclosed in the filing) | SEC |